DECODE GENETICS-*DCGN Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DECODE GENETICS-*DCGN

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (202)	8/4/2005 6:19:28 PM
From: DewDiligence_on_SI	Read Replies (1) of 313

Co didn't say but I suspect it will have to be a massively large N N=2000-2500 according to prior CC’s. Even 2,500 is not what I would call “massively large” for the second-MI setting. For instance, NVS’ just completed Diovan trial in the same setting had 15,000 patients. DCGN is hoping that an N as small as 2000-2500 will work because of the biomarkers. Most important news from yesterday’s CC: a reply from the FDA about the proposed SPA is expected on Aug 15.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next